Stay Informed

News

All News Announcements Blog GHTC in the Media Advocacy Actions
GHTC delivers statement on the global strategy on health, innovation, and intellectual property at the World Health Assembly
Air National Guard/Master Sgt. David Eichaker
May 29, 2021

GHTC delivers statement on the global strategy on health, innovation, and intellectual property at the World Health Assembly

GHTC delivered a statement at the 74th World Health Assembly calling on the World Health Organization and member states to strengthen the capacity of national and regional regulatory functions and systems. The statement, issued through the Global Health Council, also urges member states to support a resolution to strengthen local production of medicines and health technologies, as well as ensure better regional collaboration for regulatory functions.

Learn more
GHTC joins statement to the World Health Assembly on AMR, global immunization strategy
IAEA/Dean Calma
May 28, 2021

GHTC joins statement to the World Health Assembly on AMR, global immunization strategy

GHTC joined a civil society statement at the 74th World Health Assembly calling on the World Health Organization (WHO) and member states to strengthen vaccine-related research and innovation with the most vulnerable populations in mind and increase investment in R&D for new health technologies to fight antimicrobial resistance (AMR). The statement, issued through the Global Health Council, urges WHO and member states to support research on the full spectrum of product needs, including vaccine administration, storage, and delivery innovations, as well as new antimicrobials, diagnostics, and vaccines to address the threat of AMR.

Learn more
GHTC joins statement to the World Health Assembly on the global malaria strategy
IAEA/Dean Calma
May 26, 2021

GHTC joins statement to the World Health Assembly on the global malaria strategy

GHTC joined a civil society statement to the 74th World Health Assembly outlining the transformative progress achieved in developing and facilitating access to malaria prevention and treatment tools through the World Health Organization (WHO) Global Technical Strategy for Malaria 2016–2030. The statement, issued through the Medicines for Malaria Venture and PATH, urges WHO and member states to address the fragility of health systems and increase investments to drive innovation and uptake of tools, including through more efficient processes for prequalification of products and revision of guidelines.

Learn more
GHTC joins statement to World Health Assembly on health emergencies and preparedness
NLO Office, Syrian Arab Republic
May 26, 2021

GHTC joins statement to World Health Assembly on health emergencies and preparedness

GHTC joined the Global Health Council in its statement to the 74th World Health Assembly calling on the World Health Organization (WHO) and member states to prioritize R&D capacity strengthening within global frameworks to strengthen pandemic preparedness. The statement specifically urges WHO and member states to prioritize regional research and manufacturing capacity, increase International Health Regulation compliance, and strengthen medical and pharmaceutical supply chains in advance of health emergencies.

Learn more
GHTC joins CEO letter urging allocation of supplemental funds to CEPI
Asian Development Bank
May 19, 2021

GHTC joins CEO letter urging allocation of supplemental funds to CEPI

GHTC joined CEOS of major global health organizations in signing a letter to the Secretary of State and Administration of the US Agency for International Development urging expedient allocation of funding for the Coalition for Epidemic Preparedness Innovations (CEPI) from emergency global health funding included in the American Rescue Act passed in March.

PDF
GHTC delivers statement on AMR at HHS WHA listening session
CDC/ Melissa Dankel
May 13, 2021

GHTC delivers statement on AMR at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session calling on the US government to increase investment in developing new antimicrobials, vaccines, diagnostics, and other tools to combat antimicrobial resistance (AMR), including by supporting the Global Antibiotic Research and Development Partnership.

Learn more
GHTC delivers statement on GSPOA at HHS WHA listening session
PATH/Gabe Bienczycki
May 13, 2021

GHTC delivers statement on GSPOA at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session on the global strategy and plan of action on public health, innovation and intellectual property (GSPOA). GHTC encouraged the US delegation to support global efforts to strengthen regulatory capacity and local production of health technologies in low- and middle-income countries and push for the World Health Organization to develop target product profiles for key missing tools to address health threats.

Learn more
GHTC delivers statement on Immunization Agenda 2030 at HHS WHA listening session
PATH/Gabe Bienczycki
May 13, 2021

GHTC delivers statement on Immunization Agenda 2030 at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session encouraging the US delegation to work with the World Health Organization and member states to strengthen mechanisms to define vaccine-related research priorities informed by user needs. GHTC also called on the US government to robustly invest in vaccine development for priority health challenges and support research on the full spectrum of product needs, including vaccine administration tools and storage and delivery innovations.

Learn more